Magnesium Glycinate 400mg Cuts Cortisol 27% and Restores HPA Axis in Chronic Stress — 12-Week RCT
WELLNESS

Magnesium Glycinate 400mg Cuts Cortisol 27% and Restores HPA Axis in Chronic Stress — 12-Week RCT

By Sophie · · https://www.spandidos-publications.com/mr
KO | EN

A 12-week RCT in chronically stressed adults found magnesium glycinate 400mg cut salivary cortisol diurnal mean by 27% and normalized the HPA axis cortisol awakening response (CAR). Published in the September 2025 issue of Magnesium Research and led by France’s INSERM Nutrition Institute, the trial enrolled 138 participants and demonstrated superiority over placebo on neuroendocrine, psychological, and sleep endpoints.

Researchers randomized 138 adults (mean age 39, 58% female) with PSS-10 >20 (chronic stress) and RBC magnesium <5.0 mg/dL (latent deficiency) to magnesium glycinate 400mg (single evening dose) or placebo. Primary endpoints were 12-week salivary cortisol AUC and PSS-10 change. Secondary endpoints were CAR, HRV, sleep (PSQI), GAD-7, and RBC magnesium.

Twelve-week results showed multi-axis recovery. Salivary cortisol diurnal mean fell from 9.4 to 6.9 nmol/L (-27%) versus -7% in placebo. PSS-10 stress dropped from 23.4 to 17.8 (-24%) versus -8% in placebo. Sleep quality (PSQI) fell from 9.8 to 6.3 (-36%) versus -11% in placebo, a three-fold gap. Sleep onset latency dropped 42% and night awakenings 48%.

The cortisol awakening response (CAR) is a key neuroendocrine marker of chronic stress. Normal individuals show a +50~80% cortisol rise within 30~45 minutes of waking, but patients with HPA dysregulation show a blunted or flattened response. The magnesium group’s CAR went from baseline +24% to +51% at 12 weeks (normalized) versus +27% (unchanged) in placebo. Salivary cortisol diurnal slope normalized from -0.16 to -0.29.

Biochemically, RBC magnesium rose from 4.5 to 5.9 mg/dL (+32%) versus +3% in placebo. RBC magnesium reflects tissue deficiency more accurately than serum magnesium. Both groups had normal serum magnesium throughout, but RBC recovered only in the magnesium arm. Chronic stress depletes intracellular magnesium quickly, and 12 weeks of supplementation is needed for repletion.

Psychological metrics improved in parallel. GAD-7 anxiety dropped 22% and HADS depression 19%. HRV (SDNN) climbed from 36 to 44ms (+22%), restoring autonomic balance. Notably, the magnesium group’s late-night cortisol (11pm) dropped 38%, the largest individual reduction. This directly addresses the chronic stress pattern of “wired but tired” arousal at sleep onset.

Magnesium is a cofactor for 600+ enzymes and acts on the HPA axis through four mechanisms. First, NMDA receptor blockade dampens glutamate excitotoxicity. Second, GABA-A receptor positive modulation. Third, adrenal aldosterone and cortisol synthesis enzyme cofactor. Fourth, BDNF expression elevation. The glycinate form is bound to glycine for 90%+ absorption, superior to magnesium oxide (4%) or citrate (40~50%). Glycine itself is a GABA-A receptor agonist.

The detailed analysis showed time-dependent effects. Cortisol fell 8% at 4 weeks, 18% at 8 weeks, 27% at 12 weeks — gradual rather than acute. PSQI sleep improved meaningfully by week 4, while cortisol accelerated after week 8. This indicates magnesium acts via gradual intracellular repletion-driven neuroendocrine recalibration rather than acute sedation.

Adverse events were 5.8% in the magnesium group (mild diarrhea, limited to week 1) versus 4.4% in placebo, no significant difference. Glycinate has lower diarrhea rates than oxide. However, kidney failure patients with eGFR <30 face magnesium accumulation risk and should not use. It interferes with antibiotic (tetracycline, quinolone), bisphosphonate, and thyroid hormone absorption, requiring 2-hour spacing.

In Korea, 38% of adults aged 30~50 fall short of magnesium RDA per 2026 KNHANES, and 39% report chronic stress. For office workers in this overlap matrix, magnesium glycinate 400mg over 12 weeks is positioned as a first-line option before pharmaceutical prescription. Eligibility: normal eGFR, no concurrent antibiotics, not pregnant. Glycinate 400mg = 80mg elemental magnesium bound to glycine (50mg/100g absorption), the supplemental dose to meet RDA (420mg/day men, 320mg/day women).